News

Recent Letters from the Director

Guest Letter: A Path Forward: What’s Possible for Obesity Care in 2026

January 1, 2026

Last month, the administration delivered another critical victory: a landmark Medicare and Medicaid price negotiation deal for the GLP-1 medications Wegovy and Zepbound.

Obesity in the Workforce

December 3, 2025

Inclusive and supportive workplaces for people with obesity remain the exception rather than the norm.

The Changing Global Obesity Landscape

October 31, 2025

The global burden of obesity continues to rise. Without effective and collective action, overweight and obesity will continue to increase globally.

News Archive

The Connection Between Ultra-Processed Foods and Endocrine Disruptors

January 3, 2022

In this month's newsletter, we examine the relationship between ultra-processed foods and endocrine disrupting chemicals.

AI/ANs: Obesity, Food Systems, and the Pursuit of Health Equity

December 1, 2021

November is National American Indian and Alaska Native Heritage Month.

Fast Facts – Obesity and AI/AN Populations

November 30, 2021

American Indian/Alaska Natives face one of the highest rates of obesity and increased obesity-related mortality compared to other races.

Fen-Phen and Medication Mistrust

October 29, 2021

Despite the promise of increasingly effective pharmacotherapy for obesity, the rate of prescriptions for weight-loss medications in the US is surprisingly low.